UNK DY
Report
- Report Number
- 3009211636-2014-00063
- Event Type
- Malfunction
- Date Received
- October 1, 2014
- Date of Event
- July 29, 2014
- Report Date
- July 29, 2014
- Manufacturer
- COVIDIEN MANUFACTURING
- Product Code
- FJS
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
AN INVESTIGATION IS CURRENTLY UNDERWAY. UPON COMPLETION, THE RESULTS WILL BE FORWARDED.
.
IT WAS REPORTED TO COVIDIEN ON (B)(4) 2014 THAT A CUSTOMER HAD AN ISSUE WITH A UNK DIALYSIS CATHETER. THE CUSTOMER STATES THAT TWO MONCRIEF CATHETERS REPORTED AS HAVING AN ISSUE WITH INSERTION WHICH LEAD TO LEAKING AND INFECTION.
THE PRODUCT SAMPLE WAS NOT RETURNED AND NO PHOTOS WERE RECEIVED. MORE INFORMATION WAS REQUESTED TO THE CUSTOMER AND NO ADDITIONAL EVIDENCE WAS PROVIDED FOR THIS ANALYSIS. ALL THE POSSIBLE CAUSES WERE IDENTIFIED. NO LOT NUMBER WAS PROVIDED, THEREFORE, IT IS NOT POSSIBLE TO PERFORM A DHR REVIEW. THIS DEFECT HAS NOT BEEN CONFIRMED. THE PRODUCT SAMPLE WAS NOT RETURNED TO THE MANUFACTURING SITE FOR REVIEW. WITH THE AVAILABLE INFORMATION, THE MOST PROBABLE ROOT CAUSE COULD BE ATTRIBUTED TO THE USERS INSERTION/PLACEMENT METHOD EMPLOYED WHICH GENERATED ISSUES DURING THE PROCEDURE. HOWEVER WITHOUT THE SAMPLE, THIS CANNOT BE CONFIRMED. NO ADDITIONAL ACTIONS ARE REQUIRED. IT MUST BE NOTED THAT IN-PROCESS CONTROLS (SUCH AS PERSONNEL TRAINING, INCOMING QUALITY ACCEPTANCE TESTING FOR RAW MATERIAL, 100% IN PROCESS VISUAL INSPECTION AND VISUAL ACCEPTANCE SAMPLING) ARE IN PLACE TO PREVENT NONCONFORMING PRODUCT FROM LEAVING THE MANUFACTURING OPERATIONS. PER PROCEDURE, MANUFACTURING PERFORMS 100% VISUAL INSPECTION AT THE FINAL STAGE OF PRODUCTION, WHICH WOULD AVOID ISSUES IN THE CATHETER ASSEMBLY. THIS COMPLAINT WILL BE USED FOR TRACKING AND TRENDING PURPOSES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 612736 | UNK DY | UNK DY | FJS | COVIDIEN MANUFACTURING | UNK DY | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK |